{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:13:03Z","timestamp":1790111583535,"version":"4.0.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114602","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T14:03:22Z","timestamp":1418133802000},"page":"e114602","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Safety and Immunogenicity of H1\/IC31\u00ae, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells\/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"pactr201105000289276","registry":"10.18810\/pactr"}],"author":[{"given":"Klaus","family":"Reither","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Katsoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolene","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elirehema","family":"Mfinanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Kagina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Scriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren T.","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kromann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Daubenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin J.","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,9]]},"reference":[{"key":"ref1","unstructured":"WHO (2014) Global tuberculosis report 2013. WHO. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/global_report\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/global_report\/en\/<\/ext-link>. Accessed 2014 Jan 17."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"GA Colditz","year":"1994","journal-title":"JAMA J Am Med Assoc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"THM Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in na\u00efve human volunteers","volume":"28","author":"JT Van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"JT Van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.201108-1548OC","article-title":"A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and\/or Mycobacterium tuberculosis-infected adults","volume":"185","author":"TJ Scriba","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e000223","DOI":"10.1136\/bmjopen-2011-000223","article-title":"A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults","volume":"1","author":"AM Minassian","year":"2011","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e67177","DOI":"10.1371\/journal.pone.0067177","article-title":"Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) na\u00efve subjects gives comparable immunogenicity to one dose in ART+ subjects","volume":"8","author":"TN Dieye","year":"2013","journal-title":"PloS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Gu\u00e9rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"CF Von Reyn","year":"2010","journal-title":"AIDS Lond Engl"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(02)11141-X","article-title":"Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial","volume":"360","author":"A Mwinga","year":"2002","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e89612","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection","volume":"9","author":"AS Nell","year":"2014","journal-title":"PLoS ONE"},{"key":"ref12","unstructured":"Churchyard GJ, Landry B, Snowden MA, Pandian R, Douoguih M, et al. (2009) Safety and Immunogenicity of AERAS-402 in HIV-infected, BCG-vaccinated Adults With CD4+ Lymphocyte Counts Greater Than 350 Cells\/mm3. CROI 2013: S \u2013160."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.201343751","article-title":"The who\u2019s who of T-cell differentiation: human memory T-cell subsets","volume":"43","author":"YD Mahnke","year":"2013","journal-title":"Eur J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"PA Darrah","year":"2007","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1084\/jem.20052246","article-title":"Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation","volume":"203","author":"JP Casazza","year":"2006","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cyto.a.20643","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues","volume":"73","author":"V Appay","year":"2008","journal-title":"Cytom Part J Int Soc Anal Cytol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells","volume":"182","author":"T Lindenstr\u00f8m","year":"2009","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"S Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"ref19","first-page":"2222","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"CL Day","year":"2011","journal-title":"J Immunol Baltim Md 1950"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e39909","DOI":"10.1371\/journal.pone.0039909","article-title":"The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity","volume":"7","author":"R Billeskov","year":"2012","journal-title":"PLoS ONE"},{"key":"ref21","first-page":"4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"EK Forbes","year":"2008","journal-title":"J Immunol Baltim Md 1950"},{"key":"ref22","first-page":"6311","article-title":"Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"T Lindenstr\u00f8m","year":"2013","journal-title":"J Immunol Baltim Md 1950"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4<sup>+<\/sup> T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"I Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"TJ Scriba","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"B Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4161\/viru.1.5.12862","article-title":"IL-17 in protective immunity to intracellular pathogens","volume":"1","author":"SA Khader","year":"2010","journal-title":"Virulence"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","article-title":"Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing","volume":"180","author":"RN Van Zyl-Smit","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","unstructured":"WHO (2011) New WHO recommendations on use of commercial TB Interferon-Gamma Release Assays (IGRAs) in low- and middle-income countries. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/features_archive\/igra_policy24oct\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/features_archive\/igra_policy24oct\/en\/<\/ext-link>. Accessed 2014 Jan 10."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1073\/pnas.1015153108","article-title":"Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection","volume":"108","author":"KA Millington","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"C Aagaard","year":"2011","journal-title":"Nat Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:14:41Z","timestamp":1540217681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114602"}},"subtitle":[],"editor":[{"given":"Alan","family":"Landay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,9]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114602","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,9]]}}}